|
We are happy to share that additional doses of Moderna COVID-19 vaccine (6 months - 11 years) and influenza vaccine have been secured and availability has improved.
As always, please check the IIS Vaccine Advertisements for a transfer opportunity before placing an order. If you have excess doses of these vaccines, please advertise them in the IIS. If you do need to place an order, please keep in mind that the end of the season isn't far off and order responsibly.
The technical issue in the IIS that was affecting the submission of Childhood Vaccine Program (CVP) provider agreement renewals has been resolved. You may resume submitting your provider agreement renewals.
If you submitted a provider agreement on or before March 18, your agreement may have been affected by the issue that removed the selected refrigerator and freezer type on the Cold Storage Unit page. If so, your agreement will be returned and you will need to reselect the appropriate fridge/freezer type before resubmitting.
 Remember to check your IIS Messages and review the Approver Comments section of your returned agreement for updates and communications from the team reviewing your agreement!
In some regions, 2025 provider agreements will expire on March 31. You will not be able to place an order without an approved provider agreement. Submit your renewal as soon as possible to allow time for any corrections needed and avoid delays in ordering.
Provider Agreement Renewal Resources
If you haven't done so yet, ensure your clinic is ready to renew by completing the following:
- Gather practice profile data for the calendar year 1/1/25 - 12/31/25
- Ensure all thermometer calibrations are up to date
- Annual Vaccine Coordinator Training for primary and back-up vaccine coordinators completed within the current calendar year (2026)
The Washington State Department of Health (DOH) has extended the RSV monoclonal antibody administration period for infants through April 30, 2026, due to a delayed and prolonged RSV season with continued elevated activity statewide.
What providers should know:
- Continue to assess and immunize eligible infants with RSV monoclonal antibodies (nirsevimab or clesrovimab) through April 30, 2026.
- All infants under 8 months of age are eligible if:
- they have not already received nirsevimab or clesrovimab,
- have no contraindications
- were not protected through maternal RSV vaccination at least 2 weeks before birth.
-
Higher-risk infants 8-19 months in their 2nd RSV season should also be assessed and
administered RSV immunization.
- Childhood Vaccine Program ordering of RSV product will be limited to birthing hospitals and Tribal clinics.
- Birthing hospitals and Tribal clinics should place orders using the IIS by March 31, 2026.
- All other providers in need of product are encouraged to check the IIS Vaccine Advertisements for a transfer opportunity. If you have excess doses of these vaccines, please advertise them in the IIS.
- For questions about RSV immunization product ordering or dose transfers, contact us at WAChildhoodVaccines@doh.wa.gov.
- The administration period for pregnant people has not been extended - the administration period for this population ended in January.
Resources
Transfer Tip: When arranging a vaccine transfer with another CVP provider, remember to share your Organization name and Facility name! The IIS Transfer function does not currently list providers by PIN so make sure your transfer request is submitted with the correct Organization and Facility name to avoid delays in review.
|
